Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine.
Dobrin
P B
PB
Loyola University Medical Center, Maywood, Illinois 60153, USA.
Baumgartner
N
N
Anidjar
S
S
Chejfec
G
G
Mrkvicka
R
R
D000818:Animals; D001012:Aorta, Abdominal / Q000737:chemistry / Q000187:drug effects / Q000473:pathology; D017544:Aortic Aneurysm, Abdominal / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D001025:Aortitis / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D016572:Cyclosporine / Q000627:therapeutic use*; D016326:Extracellular Matrix Proteins / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016131:Lymphocyte Subsets / Q000473:pathology; D008264:Macrophages / Q000473:pathology; D008666:Metalloendopeptidases / Q000032:analysis; D008775:Methylprednisolone / Q000627:therapeutic use*; D010196:Pancreatic Elastase / Q000032:analysis / Q000633:toxicity; D051381:Rats; D011921:Rats, Inbred WKY; D017208:Rats, Wistar; D013864:Thioglycolates / Q000494:pharmacology
D016326:Extracellular Matrix Proteins; D007166:Immunosuppressive Agents; D013864:Thioglycolates; D016572:Cyclosporine; D010196:Pancreatic Elastase; D005341:Fibrinolysin; D008666:Metalloendopeptidases; D008775:Methylprednisolone